European heart group issues guidelines on 4 new anticoagulants

05/3/2013 | TheHeart.org (Montreal) (free registration)

The European Heart Rhythm Association of the European Society of Cardiology has released practice guidelines for the use of the oral anticoagulants dabigatran, rivaroxaban, apixaban and edoxaban in patients with atrial fibrillation. The guide includes clinical scenarios and information on managing bleeding risks.

View Full Article in:

TheHeart.org (Montreal) (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX